Please login to the form below
#GDPR
This page shows the latest #GDPR news and features for those working in and with pharma, biotech and healthcare.
Health leaders welcome EDPB’s opinion on adequacy of UK’s data protection standards
The EDPB said that there are key areas of alignment between the EU and the UK on data protection, as the UK had implemented the GDPR into national law before leaving
Latest news
-
Safety first: AI adoption in the healthcare sector
The GDPR introduced a right to explanation, which means that the logic of an automated decision can be challenged and the results tested – businesses will need to think carefully before building ... Where required by the GDPR, privacy impact
-
ABPI blames doctor payment disclosure dip on GDPR
or re-sought consent to meet GDPR requirements, which could explain the dip. ... GDPR applies to all industries and organisations across Europe and inevitably brings challenges for all as processes and procedures are checked,” commented the ABPI’s
-
Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more
It's not just the GDPR's big day, plus news from Medigene and Pfizer. ... most of us have been bombarded with messages from companies and organisations rushing to meet the new GDPR regulations.
-
Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval
new tighter European data privacy rules, the GDPR, come into force.
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Achieving communication excellence by targeting the right channel at the right time
Ensuring databases have the right consents and permissions, having strong GDPR and making it easy for HCPs to search and discover content via simple logging-in processes helps encourage enduring connections.
-
What Hemingway got right about patient communications
But when physicians asked if they could use these apps to manage their patients remotely, we sensed a potentially insurmountable GDPR and pharmacovigilance challenge.
-
Exploiting the value of data in pharma
In order to facilitate access to personal data there are ethical and regulatory obstacles such as GDPR compliance or operating to GxP guidelines to address, but the importance of public health
-
Mastering data protection in the pharma industry
The enhanced rights for individuals under the GDPR may also have implications for medical research. ... GDPR consent and in such case an alternative legal basis may be required.
-
Pharmaceutical social media after Cambridge Analytica
In fact, in 2018 Facebook was fined £500, 000 – the maximum allowable at the time under the law, prior to the introduction of GDPR – by the ICO, which stated that “companies
More from intelligence
Approximately 1 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
PRESS RELEASE: IMPETUS DIGITAL LAUNCHES INSITE EVENT™
InSite Event is a GDPR- and HIPAA-compliant, “one-stop-shop,” completely customizable virtual event solution.
-
Press release: InSite Event™ named one of the most innovative services of 2020
InSite Event is a GDPR- and HIPAA-compliant, “all-in-one,” completely customizable virtual event solution, ideal for medical congresses, conferences, education events, and corporate meetings.
-
Impetus Digital
The HIPAA- and GDPR-compliant Impetus InSite Platform. allows for sustained healthcare stakeholder communication, collaboration, education, and insight synthesis longitudinally.
-
Are you capitalising on your pharma exhibition presence?
However, in response to the rapid growth of technology, the GDPR has significantly modified the way we can collect, store and use personal data.
-
How to add some magic to your pharma exhibition stand design
iPads. Augmented Reality/Virtual Reality. Touch screen data capture (GDPR compliant). Holograms.
More from PMHub
Approximately 3 fully matching, plus 19 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- bluebird bio reveals plans to launch two gene therapies
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- Medmeme appoints Dr Joseph Laudano to medical affairs role
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Sarepta to submit application for Duchenne muscular dystrophy gene therapy
- Achieving communication excellence by targeting the right channel at the right time
- Successful product commercialisation: what can we learn from the rare disease setting?
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
